Article

Colliers LabNotes Interview

August 06, 2021 Ravi Samavedam

Colliers' Executive Vice President, Joseph Fetterman, spoke with Chief Innovation Officer (CINO) Azzur Group, Ravi Samavedam, for a LabNotes interview in regards to how Azzur's on-demand solutions are helping meet the emerging needs of the pharmaceutical industry and address the critical issue of limited manufacturing capacity in the market.

During the interview, Ravi explains how Azzur presents a unique value proposition for growing drug development companies by providing expertise in GMP manufacturing services, enabling its clients to focus strictly on science as well as preserve time and capital.

You can hear what Ravi has to say and learn more about Azzur's consulting capabilities and the service offerings that surround the design and implementation of cleanroom facilities in the video below.

Take a virtual tour of our on-demand cleanroom facility in Waltham, Massachusetts, here.

Ravi Samavedam

Ravi Samavedam joined Azzur Group in 2012 and is a Biochemical Engineer with more than 20 years of experience. Prior to his appointment to Chief Innovation Officer (CINO), Ravi served as President of Azzur Cleanrooms on Demand™ and previously was a General Manager of Azzur Boston. Ravi has been a part of technical operations, quality, and validation departments at some of the world’s foremost pharmaceutical manufacturers. He is an expert in phase-appropriate cGMP implementation, process validation, supplier management, and technology transfer. Ravi is an active member of industry and peer groups, and he is a frequent speaker at industry events.

Connect On Linkedin

Related Insights